Biohaven Stock Down Fund's Turnaround Bet Sparks Hope
A patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
Financial planning is crucial for securing your future. This article discusses its importance and how it can lead to better financial outcomes.
24,037 articlesA patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
Mosaic's Q3 2025 results spotlight a sharply growing Brazil business, with Brazil EBITDA up 190% year over year. Yet ...
In 2026, three popular tech ETFs tell three different stories about how to own technology: FTEC offers broad exposure...
DraftKings stock slides as a Senate measure targets prediction markets, while Penn Entertainment holds steady amid re...
A tiny $1,800 token purchase has triggered a governance attack on Moonwell, risking over $1 million in funds. Analyst...
If you’re weighing AI investing options, two popular ETFs—CHAT and XLK—show two very different paths. This guide brea...
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
This week brought a notable rise for Corcept Therapeutics as investors reacted to a major catalyst. Learn what drove ...
BitMine disclosed a multi-billion ETH stake as it moves to a public listing, redefining how companies participate in ...
Big investors are quietly using a loophole to keep buying rental properties despite bans. This article breaks down wh...
Stocks trim gains as a risk-on mood cools. The Nasdaq Composite weakens, while tech names temper their rally as trade...
Two popular ETFs both target consumer staples, but their weighting methods lead to distinct risk and return profiles....